News Conference News AHA 2024 REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients L.A. McKeown November 22, 2024
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? Michael O'Riordan October 02, 2024
News Daily News Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF Todd Neale September 20, 2024
News Conference News ESC 2024 FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients Michael O'Riordan September 01, 2024
News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Conference News ESC Heart Failure 2024 Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show Michael O'Riordan May 21, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Conference News ACC 2024 Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It Michael O'Riordan March 27, 2024
News Daily News ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain Todd Neale March 25, 2024
News Daily News ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy Todd Neale March 11, 2024
News Conference News THT 2024 Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF Michael O'Riordan March 08, 2024